Sphingosine 1-phosphate receptor regulation of N-cadherin mediates vascular stabilization

JH Paik, A Skoura, SS Chae, AE Cowan… - Genes & …, 2004 - genesdev.cshlp.org
JH Paik, A Skoura, SS Chae, AE Cowan, DK Han, RL Proia, T Hla
Genes & development, 2004genesdev.cshlp.org
Vascular stabilization, a process by which nascent vessels are invested with mural cells, is
important in angiogenesis. Here we describe the molecular basis of vascular stabilization
regulated by sphingosine 1-phosphate (S1P), a platelet-derived lipid mediator. S1P1
receptor-dependent cell-surface trafficking and activation of the cell-cell adhesion molecule
N-cadherin is essential for interactions between endothelial and mural cells. Endothelial cell
S1P1/Gi/Rac pathway induces microtubule polymerization, resulting in trafficking of N …
Vascular stabilization, a process by which nascent vessels are invested with mural cells, is important in angiogenesis. Here we describe the molecular basis of vascular stabilization regulated by sphingosine 1-phosphate (S1P), a platelet-derived lipid mediator. S1P1 receptor-dependent cell-surface trafficking and activation of the cell-cell adhesion molecule N-cadherin is essential for interactions between endothelial and mural cells. Endothelial cell S1P1/Gi/Rac pathway induces microtubule polymerization, resulting in trafficking of N-cadherin to polarized plasma membrane domains. S1P treatment modulated the phosphorylation of N-cadherin as well as p120-catenin and induced the formation of cadherin/catenin/actin complexes containing novel regulatory and trafficking factors. The net result of endothelial cell S1P1 receptor activation is the proper trafficking and strengthening of N-cadherin-dependent cell-cell adhesion with mural cells. Perturbation of N-cadherin expression with small interfering RNA profoundly attenuated vascular stabilization in vitro and in vivo. S1P-induced trafficking and activation of N-cadherin provides a novel mechanism for the stabilization of nascent blood vessels by mural cells and may be exploited to control angiogenesis and vascular diseases.
genesdev.cshlp.org